CynergisTek Announces Two Six-Figure, Multi-Year Managed Cybersecurity Service Contracts with a New Client, and an Existing Renewal
February 17 2022 - 4:20PM
Business Wire
CynergisTek to provide their ongoing flagship services to one of
their largest health system customers, and a new top-rated hospital
client
CynergisTek (NYSE American: CTEK), a leading cybersecurity,
privacy, compliance, and IT audit firm helping organizations in
highly regulated industries navigate emerging security and privacy
issues, recently expands on relationship with one of the six
divisions of a prestigious academic healthcare system located on
the west coast and adds a top-ranked hospital located in the
southeast region to their growing client base. CynergisTek has
renewed an agreement with one of its top customers to provide its
signature Compliance Assist Partner Program (CAPP) service, which
will provide the organization with ongoing cybersecurity services,
advisory services, and executive reviews of the client’s security
infrastructure for another four years. CynergisTek has also signed
a new agreement with a well-known independent nonprofit hospital to
provide its Resilience Partner Program (RPP) service, which will
provide this client with ongoing cybersecurity services
specifically focused on the client’s medical device program
enhancement for the next two years.
“This team is focused on growth, and we are making steady
progress towards that goal. Seeing our renewal rates approach
pre-COVID levels is a good sign and having clients such as these
reaffirm their confidence in our support with yet another renewal
and an altogether new managed service relationship tells me we are
doing the right things,” said Mac McMillan, President & CEO of
CynergisTek. “The market is receiving the new resilience approach
positively and they are incorporating many of the new services that
we have added in the last six months to their programs with several
more to roll out shortly. These new services allow them to be much
more proactive in their cybersecurity efforts,” he says.
CynergisTek’s CAPP and RPP managed services help organizations
improve their overall security programs. Organizations like this
west coast-based academic healthcare system already understand the
continuous value of managed services and rely on CynergisTek’s
capability to help build resilience into their programs. To this
client, the value of CynergisTek’s CAPP service is evident given
the longevity of their pre-existing relationship and the renewal
decision to increase the commitment from 3 to 4 years. Commitments
like these support CynergisTek’s incentive to expand and assist the
healthcare community with strengthening their proactive approach to
cyber threats, a methodology the RPP managed service offering has
been built on. As the industry warms up to a proactive
cybersecurity approach, attracting net new managed service
partnerships, like this southeast-based nonprofit healthcare
provider, will strengthen the healthcare industry as a whole and
together help decrease the impacts of cyber incidents.
About CynergisTek, Inc.
CynergisTek (www.cynergistek.com) is a top-ranked cybersecurity
consulting firm helping organizations in highly-regulated
industries, including those in healthcare, government, and finance
navigate emerging security and privacy issues. CynergisTek combines
intelligence, expertise, and a distinct methodology to validate a
company's security posture and ensure the team is rehearsed,
prepared, and resilient against threats. Since 2004, CynergisTek
has been dedicated to hiring and retaining experts who bring
real-life experience and hold advanced certifications to support
and educate the industry by contributing to relevant industry
associations. For more information, visit www.cynergistek.com or
follow us on Twitter or LinkedIn.
Cautionary Note Regarding Forward-Looking Statements
This release contains certain forward-looking statements
relating to the business of CynergisTek, Inc. These forward-looking
statements are within the meaning of Section 27A of the Securities
Act of 1933, as amended (the “Securities Act”) and Section 21E of
the Securities Exchange Act of 1934, as amended (the “Exchange
Act”) and can be identified by the use of forward-looking
terminology such as “believes,” “expects,” “anticipates,” “would,”
“could,” “intends,” “may,” “will,” or similar expressions. Such
forward-looking statements involve known and unknown risks and
uncertainties, including but not limited to uncertainties relating
to product/services development; long and uncertain sales cycles;
the ability to obtain or maintain proprietary intellectual property
protection; future capital requirements; competition from other
providers; the ability of the Company’s vendors to continue
supplying the Company with supplies and services at comparable
terms and prices; the Company’s ability to successfully compete and
introduce enhancements and new features that achieve market
acceptance and that keep pace with technological developments; the
Company’s ability to maintain its brand and reputation and retain
or replace its significant customers; cybersecurity risks and risks
of damage and interruptions of information technology systems; the
Company’s ability to retain key members of management and
successfully integrate new executives; the Company’s ability to
complete acquisitions, strategic investments, entry into new lines
of business, divestitures, mergers or other transactions on
acceptable terms, or at all; potential risks and uncertainties
relating to the existing and ultimate impact of COVID-19, including
the geographic spread, the severity of the virus, the duration of
the COVID-19 outbreak, actions that may be taken by governmental
authorities to contain the COVID-19 outbreak or to treat its
impact, and the potential negative impacts of COVID-19 on the
global economy and financial markets, and other factors that may
cause actual results to be materially different from those
described herein as anticipated, believed, estimated or expected.
Certain of these risks and uncertainties are or will be described
in greater detail in the Company’s Form 10-K and Form 10-Q filings
with the Securities and Exchange Commission, which are available at
http://www.sec.gov. Given the risks and uncertainties, readers
should not place undue reliance on any forward-looking statement
and should recognize that the statements are predictions of future
results which may not occur as anticipated. Many of the risks
listed above have been, and may further be, exacerbated by the
COVID-19 pandemic, including its impact on the healthcare industry.
Actual results could differ materially from those anticipated in
the forward-looking statements and from historical results, due to
the risks and uncertainties described herein, as well as others not
now anticipated. CynergisTek is under no obligation (and expressly
disclaims any such obligation) to update or alter its
forward-looking statements whether as a result of new information,
future events, or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220217005931/en/
CynergisTek Investor Relations Contact: CynergisTek, Inc.
Bryan Flynn (512) 402-8550 x7 InvestorRelations@cynergistek.com
CynergisTek Media Contact: Allison + Partners Jaime Tero
415-755-8639 jaime.tero@allisonpr.com
CynergisTek (AMEX:CTEK)
Historical Stock Chart
From Mar 2024 to Apr 2024
CynergisTek (AMEX:CTEK)
Historical Stock Chart
From Apr 2023 to Apr 2024